Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DaVita HealthCare Partner (NY:DVA)

149.35 +5.08 (+3.52%)
Streaming Delayed Price Updated: 2:28 PM EST, Feb 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DaVita HealthCare Partner

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
News headline image
Weibo, XPeng, Li Auto And Other Big Losers From Friday ↗
U.S. stocks closed higher on Friday, with the Dow Jones gaining more than 800 points. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
News headline image
Why Pinterest Shares Jumped Around 14%; Here Are 69 Biggest Movers From Friday ↗
Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) jumped 153.9% to close at $3.30 on Friday. 
Via Benzinga
News headline image
DaVita (DVA) Q3 2022 Earnings Call Transcript ↗
DVA earnings call for the period ending September 30, 2022. 
Via The Motley Fool
News headline image
Nasdaq Climbs 275 Points; S&P 500 Rises Over 2% ↗
U.S. stocks extended gains toward the end of trading, with the Nasdaq Composite surging more than 200 points on Friday. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Gainers 
Via Benzinga
News headline image
$100 Invested In This Stock 20 Years Ago Would Be Worth $900 Today ↗
DaVita (NYSE:DVA) has outperformed the market over the past 20 years by 4.09% on an annualized basis producing an average annual return of 11.52%. Currently, DaVita has a market capitalization of $6.63... 
Via Benzinga
News headline image
Dow Jumps 600 Points; Crude Oil Down Over 1% ↗
U.S. stocks extended gains midway through trading, with the Dow Jones surging more than 600 points on Friday. 
Via Benzinga
News headline image
2 Market-Moving Stocks You Can't Afford to Ignore ↗
Friday's market action saw volatility both upward and downward. 
Via The Motley Fool
News headline image
What 4 Analyst Ratings Have To Say About DaVita ↗
Analysts have provided the following ratings for DaVita (NYSE:DVA) within the last quarter: 
Via Benzinga
News headline image
Why Edwards Lifesciences Shares Are Trading Lower By Around 17%? Here Are 47 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) surged 179% to $3.6301. 
Via Benzinga
News headline image
US Stocks Mostly Higher; Dow Surges 300 Points ↗
U.S. stocks traded mostly higher this morning, with the Dow Jones surging more than 300 points on Friday. 
Via Benzinga
News headline image
Dialysis Provider DaVita Slashes FY22 Earnings Outlook Citing Continued Pandemic Impact, Shares Fall ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Gainers Nuvalent (NASDAQ:NUVL) stock increased by 15.9% to $25.5 during Friday's pre-market session. The company's market cap stands at $1.2 billion. 
Via Benzinga
News headline image
Recap: DaVita Q3 Earnings ↗
DaVita (NYSE:DVA) reported its Q3 earnings results on Friday, October 28, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Earnings DaVita missed estimated earnings by... 
Via Benzinga
News headline image
Earnings Scheduled For October 28, 2022 ↗
Companies Reporting Before The Bell • TAL Education (NYSE:TAL) is projected to report quarterly earnings at $0.01 per share on revenue of $242.62 million. 
Via Benzinga
News headline image
DaVita's Earnings: A Preview ↗
DaVita (NYSE:DVA) is set to give its latest quarterly earnings report on Friday, 2022-10-28. Here's what investors need to know before the announcement. Analysts estimate that DaVita will report an... 
Via Benzinga
News headline image
7 Warren Buffett Stocks to Buy and Hold for the Next Decade ↗
Intelligent investors know that purchasing Warren Buffett stocks to buy and hold will work in the long-term. 
Via InvestorPlace
Mighty Mitochondria: This Company is Developing A Novel Drug for Kidney Disease By Targeting The Powerhouse Of Human Cells
You may remember learning that mitochondria are the powerhouse of the cells, but do you know the dangers that result if these cell superheroes get sick? 
Via TheNewswire.com
News headline image
Mighty Mitochondria: This Company is Developing A Novel Drug for Kidney Disease By Targeting The Powerhouse Of Human Cells ↗
You may remember learning that mitochondria are the powerhouse of the cells, but do you know the dangers that result if these cell superheroes get sick?  
Via Benzinga
News headline image
The 7 Most Undervalued Mid-Cap Stocks to Buy Now ↗
Here are some of the most undervalued mid-cap stocks to buy now. 
Via InvestorPlace
News headline image
Federman & Sherwood Investigates DaVita, Inc. for Data Breach
From Federman & Sherwood
Via Business Wire
News headline image
7 Undervalued Stocks That Everyone Is Missing Out On ↗
All of these undervalued stocks have above-average free cash flow yields and should rebound in the longer term. 
Via InvestorPlace
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 19, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Meta Platforms Price Target Cut By This Analyst, Plus BMO Capital Predicts $223 For Salesforce ↗
Morgan Stanley boosted the price target for Meta Platforms, Inc. (NASDAQ: META) from $280 to $225. Meta shares fell 2.1% to $171.01 in pre-market trading. 
Via Benzinga
News headline image
Recap: DaVita Q2 Earnings ↗
DaVita (NYSE:DVA) reported its Q2 earnings results on Monday, August 1, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings DaVita beat estimated earnings by 10.05%,... 
Via Benzinga
News headline image
Addus HomeCare's Earnings: A Preview ↗
Addus HomeCare (NASDAQ:DVA) is set to give its latest quarterly earnings report on Monday, 2022-08-01. Here's what investors need to know before the announcement. Analysts estimate that Addus HomeCare... 
Via Benzinga
News headline image
Why Shares Of DaVita Are Down Today ↗
Shares of DaVita Inc. (NYSE: DVA) are trading lower today in sympathy Fresenius Medical Care AG & Co (NYSE: FMS), which provided a bearish 2022 outlook and withdrew its 2025 targets.  
Via Benzinga
News headline image
12 Stocks Investors Want To See ↗
A look at some very inexpensive growth stocks and a few inexpensive dividend growth stocks. 
Via Talk Markets
News headline image
Earnings Scheduled For August 1, 2022 ↗
Companies Reporting Before The Bell • Bon Natural Life (NASDAQ:BON) is projected to report earnings for its first quarter. 
Via Benzinga
News headline image
6 Stocks Insiders Are Buying Now ↗
These are 6 stocks insiders are buying now. Execs buying shares now want to get in before Q2 earnings come out - a good sign for investors. 
Via InvestorPlace
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.